200 related articles for article (PubMed ID: 26177355)
1. The Expression of GDF-15 in the Human Vitreous in the Presence of Retinal Pathologies with an Inflammatory Component.
Ilhan HD; Bilgin AB; Toylu A; Dogan ME; Apaydin KC
Ocul Immunol Inflamm; 2016; 24(2):178-83. PubMed ID: 26177355
[TBL] [Abstract][Full Text] [Related]
2. A comparison of sex steroid concentration levels in the vitreous and serum of patients with vitreoretinal diseases.
Nishikawa Y; Morishita S; Horie T; Fukumoto M; Sato T; Kida T; Oku H; Sugasawa J; Ikeda T; Nakamura K
PLoS One; 2017; 12(7):e0180933. PubMed ID: 28704441
[TBL] [Abstract][Full Text] [Related]
3. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment.
Ogata N; Tombran-Tink J; Nishikawa M; Nishimura T; Mitsuma Y; Sakamoto T; Matsumura M
Am J Ophthalmol; 2001 Sep; 132(3):378-82. PubMed ID: 11530051
[TBL] [Abstract][Full Text] [Related]
4. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
Er H; Doğanay S; Ozerol E; Yürekli M
Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
[TBL] [Abstract][Full Text] [Related]
6. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
7. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
8. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
11. Decreased hyaluronan concentration during primary rhegmatogenous retinal detachment.
Kaprinis K; Symeonidis C; Papakonstantinou E; Tsinopoulos I; Dimitrakos SA
Eur J Ophthalmol; 2016 Nov; 26(6):633-638. PubMed ID: 27198637
[TBL] [Abstract][Full Text] [Related]
12. Transscleral permeation of subtenon triamcinolone in different vitreoretinal diseases.
Shen L; Mao J; Chen Y; Sun S; Han Y; Cheng L
Ophthalmology; 2015 Mar; 122(3):649-51. PubMed ID: 25439434
[No Abstract] [Full Text] [Related]
13. Level of vitreous alpha-B crystallin in eyes with rhegmatogenous retinal detachment.
Baba T; Oshitari T; Yamamoto S
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1251-4. PubMed ID: 25311653
[TBL] [Abstract][Full Text] [Related]
14. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Am J Ophthalmol; 2000 May; 129(5):678-80. PubMed ID: 10844070
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107
[TBL] [Abstract][Full Text] [Related]
17. Profiles of Inflammatory Cytokines in the Vitreous Fluid from Patients with Rhegmatogenous Retinal Detachment and Their Correlations with Clinical Features.
Takahashi S; Adachi K; Suzuki Y; Maeno A; Nakazawa M
Biomed Res Int; 2016; 2016():4256183. PubMed ID: 28074184
[No Abstract] [Full Text] [Related]
18. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
19. Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients.
Maruichi M; Oku H; Takai S; Muramatsu M; Sugiyama T; Imamura Y; Minami M; Ueki M; Satoh B; Sakaguchi M; Miyazaki M; Ikeda T
Curr Eye Res; 2004; 29(4-5):321-5. PubMed ID: 15590479
[TBL] [Abstract][Full Text] [Related]
20. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
